Graham Capital Management L.P. Has $487,000 Stock Position in Alphatec Holdings, Inc. (NASDAQ:ATEC)

Graham Capital Management L.P. lowered its position in Alphatec Holdings, Inc. (NASDAQ:ATEC - Free Report) by 70.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 53,069 shares of the medical technology company's stock after selling 126,536 shares during the quarter. Graham Capital Management L.P.'s holdings in Alphatec were worth $487,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the business. R Squared Ltd acquired a new stake in shares of Alphatec during the 4th quarter valued at $29,000. Comerica Bank raised its holdings in Alphatec by 66.8% during the 4th quarter. Comerica Bank now owns 3,116 shares of the medical technology company's stock worth $29,000 after buying an additional 1,248 shares during the period. Nisa Investment Advisors LLC lifted its stake in Alphatec by 973.3% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,669 shares of the medical technology company's stock valued at $43,000 after buying an additional 4,234 shares in the last quarter. Quarry LP boosted its holdings in shares of Alphatec by 79.2% in the fourth quarter. Quarry LP now owns 5,374 shares of the medical technology company's stock worth $49,000 after buying an additional 2,375 shares during the period. Finally, Newton One Investments LLC acquired a new stake in Alphatec during the 4th quarter valued at $50,000. 66.35% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Alphatec news, EVP David Sponsel sold 33,732 shares of the firm's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $10.83, for a total transaction of $365,317.56. Following the completion of the sale, the executive vice president now directly owns 668,977 shares in the company, valued at $7,245,020.91. This trade represents a 4.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Scott Lish sold 12,000 shares of the business's stock in a transaction on Monday, May 5th. The shares were sold at an average price of $12.12, for a total value of $145,440.00. Following the completion of the sale, the chief operating officer now owns 826,251 shares of the company's stock, valued at $10,014,162.12. This trade represents a 1.43% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 126,945 shares of company stock worth $1,416,352 over the last ninety days. Company insiders own 22.80% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ATEC. StockNews.com raised Alphatec from a "sell" rating to a "hold" rating in a research note on Friday, February 28th. Needham & Company LLC restated a "buy" rating and set a $16.00 price target on shares of Alphatec in a report on Friday, May 2nd. Piper Sandler reiterated an "overweight" rating and issued a $15.00 price objective (up previously from $13.00) on shares of Alphatec in a research note on Friday, May 2nd. HC Wainwright reissued a "buy" rating and set a $20.00 target price on shares of Alphatec in a research note on Monday, April 14th. Finally, Barclays lifted their price objective on Alphatec from $20.00 to $21.00 and gave the company an "overweight" rating in a research report on Wednesday, January 22nd. Two research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $17.89.

Alphatec Price Performance

NASDAQ:ATEC traded down $0.08 during trading hours on Wednesday, reaching $12.89. The company had a trading volume of 147,242 shares, compared to its average volume of 2,028,056. The firm has a market capitalization of $1.88 billion, a PE ratio of -10.06 and a beta of 1.06. Alphatec Holdings, Inc. has a one year low of $4.88 and a one year high of $13.14. The stock has a 50-day moving average of $10.87 and a two-hundred day moving average of $10.46. The company has a quick ratio of 1.15, a current ratio of 2.32 and a debt-to-equity ratio of 30.21.

Alphatec (NASDAQ:ATEC - Get Free Report) last released its earnings results on Thursday, May 1st. The medical technology company reported ($0.35) EPS for the quarter, missing analysts' consensus estimates of ($0.12) by ($0.23). The business had revenue of $169.18 million for the quarter, compared to analyst estimates of $167.57 million. Alphatec had a negative return on equity of 541.39% and a negative net margin of 31.06%. Alphatec's revenue was up 22.2% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.34) EPS. Analysts forecast that Alphatec Holdings, Inc. will post -1.08 earnings per share for the current year.

Alphatec Company Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.